Free Trial

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stock Price Down 2.6% - Time to Sell?

RHÖN-KLINIKUM Aktiengesellschaft logo with Medical background

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report) shares were down 2.6% during trading on Wednesday . The company traded as low as €15.10 ($16.97) and last traded at €15.10 ($16.97). Approximately 27 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 43,281 shares. The stock had previously closed at €15.50 ($17.42).

RHÖN-KLINIKUM Aktiengesellschaft Trading Up 0.8 %

The stock has a market capitalization of $890.61 million, a price-to-earnings ratio of 19.85, a price-to-earnings-growth ratio of 26.77 and a beta of -0.13. The company's 50 day moving average is €14.19 and its 200 day moving average is €13.89.

About RHÖN-KLINIKUM Aktiengesellschaft

(Get Free Report)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.

Featured Stories

Should You Invest $1,000 in RHÖN-KLINIKUM Aktiengesellschaft Right Now?

Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.

While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines